[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 48 of about 48
1. Thomas EO, Gordon J, Smith-Thomas S, Cramer SF: Diffuse uterine leiomyomatosis with uterine rupture and benign metastatic lesions of the bone. Obstet Gynecol; 2007 Feb;109(2 Pt2):528-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffuse uterine leiomyomatosis with uterine rupture and benign metastatic lesions of the bone.
  • BACKGROUND: We report a case of diffuse uterine leiomyomatosis in pregnancy complicated by uterine rupture and dissemination to the bone.
  • CASE: A 35-year-old nulliparous woman with a history of uterine leiomyoma presented at term with fetal demise.
  • Failed induction of labor and hemodynamic instability due to uterine rupture resulted in a cesarean hysterectomy.
  • The diagnosis of diffuse uterine leiomyomatosis with metastasis was made on histology of the resected uterus and fine-needle aspiration biopsy of the bone.
  • CONCLUSION: Diffuse uterine leiomyomatosis should be considered in pregnant women with a history of uterine fibroids and peripartum hemorrhage.
  • [MeSH-major] Bone Neoplasms / diagnosis. Fetal Death. Leiomyomatosis / diagnosis. Pregnancy Complications, Neoplastic / diagnosis. Prenatal Diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Cesarean Section. Diagnosis, Differential. Female. Humans. Hysterectomy. Neoplasm Metastasis. Pregnancy. Pregnancy Trimester, First. Tomography, X-Ray Computed. Uterine Rupture


2. Carranza Lira S: [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth]. Ginecol Obstet Mex; 2008 Oct;76(10):610-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Relación de la terapia hormonal, la tibolona y los SERMs con el crecimiento de miomas en la mujer posmenopáusica.
  • Myomas (both leiomyomas and fibromas) are the most frequent benign uterine tumors in women, they can be found in 77% of hysterectomy specimens.
  • A study in patients without myomas demonstrated this type tumors production (5%) after receiving transdermical-oral hormonal combination during 24 months, and they were absent in patients with only oral therapy.
  • [MeSH-major] Estrogen Receptor Modulators / adverse effects. Hormone Replacement Therapy / adverse effects. Leiomyoma / pathology. Norpregnenes / adverse effects. Postmenopause. Selective Estrogen Receptor Modulators / adverse effects. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Hormone Replacement Therapy.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19062511.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Mexico
  • [Chemical-registry-number] 0 / Estrogen Receptor Modulators; 0 / Norpregnenes; 0 / Selective Estrogen Receptor Modulators; FF9X0205V2 / tibolone
  • [Number-of-references] 34
  •  go-up   go-down


3. Hrgović Z, Kulas T, Habek D, Izetbegović S, Hrgović I: [New options in the diagnosis and management of uterine myoma]. Med Arh; 2008;62(4):234-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [New options in the diagnosis and management of uterine myoma].
  • Myoma accounts for nearly 95% of all benign tumors of female genital organs and is the most common neoplasm of female genital tract.
  • Along with thorough history and gynecologic examination, ultrasound study is of utmost importance in the diagnosis of myoma; magnetic resonance (MR) study may also be required in rare cases.
  • A number of therapeutic options are available for the management of myoma, ranging from medicamentous therapy through operative procedures (e.g., total or supracervical hysterectomy or myoma enucleation) and novel non-operative procedures (e.g., embolization of uterine artery (EUA) and magnetic resonance guided focused ultrasound (MRgFUS).
  • Therapeutic choice should rely on the patient's decision for or against treatment, sparing the uterus.
  • [MeSH-major] Leiomyoma / therapy. Uterine Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19145810.001).
  • [Journal-full-title] Medicinski arhiv
  • [ISO-abbreviation] Med Arh
  • [Language] bos
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Bosnia and Herzegovina
  • [Number-of-references] 61
  •  go-up   go-down


Advertisement
4. Manjunatha HK, Ramaswamy AS, Kumar BS, Kumar SP, Krishna L: Lipoleiomyoma of uterus in a postmenopausal woman. J Midlife Health; 2010 Jul;1(2):86-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoleiomyoma of uterus in a postmenopausal woman.
  • Lipoleiomyomas are uncommon benign neoplasms of uterus and are considered to be a variant of uterine myomas.
  • These tumors generally occur in asymptomatic obese perimenopausal or menopausal women.
  • We report this case of uterine lipoleiomyoma because of its rarity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Korean Med Sci. 2001 Apr;16(2):250-2 [11306758.001]
  • [Cites] Pathology. 1991 Oct;23(4):360-2 [1784529.001]
  • [Cites] Int J Gynaecol Obstet. 1999 Oct;67(1):47-9 [10576241.001]
  • [Cites] Acta Pathol Jpn. 1991 Feb;41(2):164-9 [2042491.001]
  • [Cites] Pathol Res Pract. 1994 Apr;190(4):378-83 [8078806.001]
  • [Cites] Pathologica. 1996 Apr;88(2):132-4 [8927448.001]
  • (PMID = 21716761.001).
  • [ISSN] 0976-7819
  • [Journal-full-title] Journal of mid-life health
  • [ISO-abbreviation] J Midlife Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3122497
  • [Keywords] NOTNLM ; Lipoleiomyoma / menopause / smooth muscle / uterus
  •  go-up   go-down


5. Loffroy R, Nezzal N, Mejean N, Sagot P, Krausé D: Lipoleiomyoma of the uterus: imaging features. Gynecol Obstet Invest; 2008;66(2):73-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoleiomyoma of the uterus: imaging features.
  • BACKGROUND: Lipoleiomyoma is an extremely rare, benign, uterine tumor that requires no treatment when asymptomatic.
  • METHODS: A uterine lipoleiomyoma in a 68-year-old asymptomatic woman exhibited highly suggestive features by ultrasound, multislice spiral computed tomography (CT), and magnetic resonance imaging (MRI).
  • RESULTS: The ultrasound findings were non-specific.
  • CT scan showed an 8 x 7 cm well-defined fatty mass of the uterine body.
  • On T(2)-weighted MR images, fat content within the tumor was confirmed because of evident chemical shift artifact.To our knowledge, the findings provided by these three modalities used in combination have not been reported previously in the gynecologic literature.
  • CONCLUSION: The data yielded by CT and MRI on the fatty nature of the lesion are valuable in diagnosing this entity.The final pathological examination results confirmed the diagnosis of lipoleiomyoma.
  • [MeSH-major] Leiomyoma / diagnosis. Lipoma / diagnosis. Uterine Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel.
  • (PMID = 18431071.001).
  • [ISSN] 1423-002X
  • [Journal-full-title] Gynecologic and obstetric investigation
  • [ISO-abbreviation] Gynecol. Obstet. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


6. Chen XD, Shi HY, Zhang XF: [Clinicopathologic analysis of 102 cases of mixed epithelial and mesenchymal tumors of the uterus]. Zhonghua Fu Chan Ke Za Zhi; 2007 Apr;42(4):219-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathologic analysis of 102 cases of mixed epithelial and mesenchymal tumors of the uterus].
  • OBJECTIVE: To study the clinical and pathologic features, histological criteria and pathologic factors contributing to diagnosis of mixed epithelial and mesenchymal tumors (mixed müllerian tumors, MMT) of the uterus.
  • METHODS: A retrospective study of 102 cases of MMT of the uterus (74 adenofibromas including 9 recurrent cases, 3 atypical polypoid adenomyomas, 2 carcinofibromas, 10 adenosarcomas and 13 carcinosarcomas) was undertaken.
  • Clinical signs included pelvic mass, uterine polyps, and enlarged uterus.
  • Benign MMT usually presented as exophytic polypoid masses extending into the uterine cavity or protruding through the external os, often broad-based, lobulated and papillary.
  • It was hard to distinguish low-grade malignant MMT from the benign ones by gross appearance.
  • MMT were classified according to whether these elements were benign or malignant.
  • Nine cases of adenofibroma without unique features for the diagnosis of adenosarcoma recurred at postoperative intervals of 3 to 96 months.
  • Recurrent tumors were almost always confined to the original site.
  • CONCLUSIONS: Uterine MMT tumors according to WHO diagnostic criteria are not rare.
  • The differential diagnosis depends on a multifactorial analysis.
  • The recurrent adenofibromas may be a kind of borderline tumors with benign appearances and malignant behavior.
  • [MeSH-major] Mixed Tumor, Mullerian / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adenofibroma / pathology. Adenomyoma / pathology. Adolescent. Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Epithelium / pathology. Female. Humans. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17631758.001).
  • [ISSN] 0529-567X
  • [Journal-full-title] Zhonghua fu chan ke za zhi
  • [ISO-abbreviation] Zhonghua Fu Chan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


7. Winter LM, Sommer G, Bongartz G: High-field magnetic resonance imaging of the pelvis: uterus, ovary, and prostate gland. Top Magn Reson Imaging; 2010 Jun;21(3):177-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-field magnetic resonance imaging of the pelvis: uterus, ovary, and prostate gland.
  • It has given proof of its usefulness in the diagnosis of several benign and malignant disorders, and it is routinely used for the local staging of different tumors even when confined to specific parts of a pelvic organ.
  • Definition of high field seems fuzzy because of the availability of MRI machines with 3, 7 T, or higher; therefore, the general aspects of MRI of pelvic structures with emphasis on uterus, ovary, and prostate gland and attention to promising newer techniques such as 3 T, dynamic contrast imaging, and diffusion-weighted imaging are reviewed in this article.
  • [MeSH-major] Imaging, Three-Dimensional / methods. Magnetic Resonance Imaging / methods. Pelvic Neoplasms / diagnosis. Radiographic Image Enhancement
  • [MeSH-minor] Diffusion Magnetic Resonance Imaging / methods. Diffusion Magnetic Resonance Imaging / trends. Female. Forecasting. Humans. Male. Neoplasm Invasiveness / pathology. Neoplasm Staging. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / pathology. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / pathology. Radiation Effects. Risk Assessment. Sensitivity and Specificity. Signal-To-Noise Ratio. Uterine Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21847037.001).
  • [ISSN] 1536-1004
  • [Journal-full-title] Topics in magnetic resonance imaging : TMRI
  • [ISO-abbreviation] Top Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


8. Shaco-Levy R, Piura B: Uterine adenolipoleiomyoma: a tumor with potential of aggressive behavior. Int J Gynecol Pathol; 2008 Apr;27(2):252-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenolipoleiomyoma: a tumor with potential of aggressive behavior.
  • An unusual uterine adenolipoleiomyoma forming intramural and subserosal masses and recurring within 16 months in the form of huge coalescent uterine masses is described.
  • Histology showed the mass to be composed of benign-appearing smooth muscle, mature adipose tissue, and bland endocervical-type glands.
  • The recurrent adenolipoleiomyoma contained, in addition, benign-appearing endometrial-type glands and stroma and showed small foci of atypically proliferating endocervical-type epithelium.
  • This is the fourth report of adenolipoleiomyoma within the uterus, the second with an intramural location, and the first with an aggressive behavior in the form of massive local recurrence.
  • [MeSH-major] Leiomyoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Neoplasm Invasiveness. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Uterus / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18317215.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Dominical VM, Cavellani CL, Rocha LP, Corrêa RR, Pereira Gde A, Teixeira Vde P: Chagas disease and gynecologic neoplasias. Ann Diagn Pathol; 2010 Oct;14(5):337-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chagas disease and gynecologic neoplasias.
  • The objective was to determine the occurrence of gynecologic neoplasia (GN) and demographic characteristics in patients with Chagas disease (CD).
  • The most common benign neoplasm was uterine leiomyoma, and malignant, carcinoma of the cervix.
  • [MeSH-major] Carcinoma / pathology. Chagas Disease / pathology. Leiomyoma / pathology. Trypanosoma cruzi. Uterine Cervical Neoplasms / pathology. Uterine Neoplasms / pathology


10. Piekutowski K, Makarewicz R, Zachara BA: The antioxidative role of selenium in pathogenesis of cancer of the female reproductive system. Neoplasma; 2007;54(5):374-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, the aim of our present study was to compare the selenium status and GSH-Px activity in the plasma of 22 healthy women, 50 individuals suffering from cancer of uterine cervix, uterine corpus or ovary, and 49 women diagnosed with benign neoplasia of the uterine corpus or ovary.
  • In addition, the selenium concentration was measured in postoperative cancer tissues, benign tumors, and histopatologically healthy surgical margins of the aforementioned patients.
  • An average selenium concentration and GSH-Px activity in blood plasma of cancer patients and benign neoplasia patients was significantly lower than in the plasma of healthy women.
  • Postoperative tissues of patients revealed significantly higher selenium concentrations in cancer tissues of uterine cervix and corpus, and benign tumors of uterine corpus, as compared to corresponding healthy tissue margins.
  • Higher accumulation of selenium in these neoplastic tissues might reflect a compensatory up-regulation of antioxidant defense systems in tumors that often undergo a persistent oxidative stress.
  • [MeSH-major] Antioxidants / pharmacology. Genital Neoplasms, Female / physiopathology. Selenium / pharmacology

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • Hazardous Substances Data Bank. SELENIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17688366.001).
  • [ISSN] 0028-2685
  • [Journal-full-title] Neoplasma
  • [ISO-abbreviation] Neoplasma
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Slovakia
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Reactive Oxygen Species; H6241UJ22B / Selenium
  •  go-up   go-down


11. Poujade O, Genin AS, Dhouha M, Luton D: A benign metastasizing leiomyoma involving a nodule in the pulmonary artery: case and literature review. Eur J Gynaecol Oncol; 2010;31(3):329-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A benign metastasizing leiomyoma involving a nodule in the pulmonary artery: case and literature review.
  • Benign metastasizing leiomyoma (BML) is a rare disease defined as a primary benign uterine tumor with "metastatic" lesions preferentially occurring in the lung, pelvis and lymph nodes.
  • A 55-year-old woman complaining of abdominal discomfort, heaviness and asthenia was admitted to our hospital for investigation of a voluminous uterine mass with high vascularization and three pulmonary nodules.
  • The resection of the mass by laparotomy was complicated by uncontrolled severe hemorrhage due to vascular proliferation, requiring multiple transfusions, packing the cavity and postoperative uterine artery embolization.
  • The comparison of hysterectomy and lobectomy pieces showed a similar aspect, leading thus to the diagnosis of BML.
  • Awareness of this rare entity should potentially avoid under-diagnosis and difficulties due to hemorrhage during surgery.
  • [MeSH-major] Leiomyoma / pathology. Lung Neoplasms / secondary. Pulmonary Artery / pathology. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21077481.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  •  go-up   go-down


12. Ko ML, Lin HW, Chen SC, Pan HS: Should cystoscopy be routinely performed after laparoscopy-assisted vaginal hysterectomy? Minim Invasive Ther Allied Technol; 2008;17(3):195-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were eighty patients who underwent LAVH for benign tumors of the uterus (adenomyosis and myoma), uterine prolapse, persistent intraepithelial neoplasm of the cervix (CIN3) and cervical carcinoma in situ (CIS).
  • From among the 80 patients who underwent LAVH, 52 had myoma, 19 had adenomyosis, six patients had uterine prolapse, one had CIS and seven patients were diagnosed to have CIN3.
  • [MeSH-major] Cystoscopy / methods. Hysterectomy, Vaginal / adverse effects. Intraoperative Complications / diagnosis. Laparoscopy / adverse effects
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Hematuria / etiology. Humans. Middle Aged. Postoperative Complications / prevention & control. Retrospective Studies. Stents. Ureter / injuries. Ureter / surgery. Ureteral Obstruction / diagnosis. Ureteral Obstruction / etiology. Ureteral Obstruction / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18608998.001).
  • [ISSN] 1365-2931
  • [Journal-full-title] Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
  • [ISO-abbreviation] Minim Invasive Ther Allied Technol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


13. Luo X, Chegini N: The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma. Semin Reprod Med; 2008 Nov;26(6):500-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyomas are benign uterine tumors considered to arise from transformation of myometrial cells.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Stem Cells. 2008 Feb;26(2):356-63 [17991914.001]
  • [Cites] J Cell Mol Med. 2008 Jan-Feb;12(1):227-40 [18182067.001]
  • [Cites] Hum Gene Ther. 2008 Jan;19(1):17-26 [18211225.001]
  • [Cites] J Biol Chem. 2008 Apr 11;283(15):9836-43 [18281287.001]
  • [Cites] Obstet Gynecol. 2008 May;111(5):1129-36 [18448745.001]
  • [Cites] Int J Biochem Cell Biol. 2008;40(6-7):1068-78 [18243766.001]
  • [Cites] Fertil Steril. 2008 Jun;89(6):1771-6 [17765232.001]
  • [Cites] Cell Signal. 2008 Aug;20(8):1409-14 [18296024.001]
  • [Cites] Semin Reprod Med. 2008 Jul;26(4):298-312 [18756407.001]
  • [Cites] Environ Health Perspect. 2000 Oct;108 Suppl 5:785-90 [11035983.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Apr;86(4):1707-15 [11297607.001]
  • [Cites] Clin Obstet Gynecol. 2001 Jun;44(2):327-34 [11344996.001]
  • [Cites] Front Biosci. 2002 Apr 1;7:e91-115 [11897550.001]
  • [Cites] Oncogene. 2002 May 2;21(19):2971-80 [12082527.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):114-21 [12095500.001]
  • [Cites] Mol Hum Reprod. 2002 Dec;8(12):1071-8 [12468639.001]
  • [Cites] Mol Hum Reprod. 2003 Sep;9(9):541-9 [12900513.001]
  • [Cites] Cell. 2004 Jan 23;116(2):281-97 [14744438.001]
  • [Cites] Int J Exp Pathol. 2003 Dec;84(6):267-79 [14748746.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Jun;40(2):97-108 [15101043.001]
  • [Cites] Hum Reprod Update. 2004 May-Jun;10(3):207-20 [15140868.001]
  • [Cites] Semin Reprod Med. 2004 May;22(2):83-90 [15164303.001]
  • [Cites] Semin Reprod Med. 2004 May;22(2):91-103 [15164304.001]
  • [Cites] Am J Physiol Cell Physiol. 2004 Oct;287(4):C1012-22 [15201140.001]
  • [Cites] Am J Obstet Gynecol. 1989 Mar;160(3):637-41 [2929683.001]
  • [Cites] Mol Hum Reprod. 1997 May;3(5):411-8 [9239726.001]
  • [Cites] Baillieres Clin Obstet Gynaecol. 1998 Jun;12(2):225-43 [10023420.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Nov;89(11):5549-57 [15531510.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):1060-5 [16878133.001]
  • [Cites] Cancer Res. 2006 Sep 15;66(18):9090-8 [16982751.001]
  • [Cites] J Clin Oncol. 2006 Oct 10;24(29):4677-84 [16966691.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6156-62 [17028594.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6163-9 [17028595.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6176-87 [17028597.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6202-10 [17028600.001]
  • [Cites] Blood. 2006 Nov 1;108(9):3068-71 [16849646.001]
  • [Cites] Steroids. 2006 Nov;71(11-12):960-5 [16935316.001]
  • [Cites] Nat Rev Cancer. 2006 Nov;6(11):857-66 [17060945.001]
  • [Cites] Childs Nerv Syst. 2006 Nov;22(11):1419-25 [16983573.001]
  • [Cites] J Cell Sci. 2006 Dec 1;119(Pt 23):4803-10 [17130294.001]
  • [Cites] Nucleic Acids Res. 2006;34(20):5863-71 [17062625.001]
  • [Cites] PLoS One. 2006;1:e116 [17205120.001]
  • [Cites] J Appl Physiol (1985). 2007 Jan;102(1):306-13 [17008435.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):152-64 [17158157.001]
  • [Cites] J Biol Chem. 2007 Jan 26;282(4):2135-43 [17135249.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9 [17242365.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Apr;46(4):336-47 [17243163.001]
  • [Cites] J Invest Dermatol. 2007 Mar;127(3):526-37 [17299435.001]
  • [Cites] Circ Res. 2007 Feb 16;100(3):416-24 [17234972.001]
  • [Cites] Genes Dev. 2007 Mar 1;21(5):578-89 [17344418.001]
  • [Cites] Mol Endocrinol. 2007 May;21(5):1132-47 [17312270.001]
  • [Cites] Oncogene. 2007 Apr 26;26(19):2799-803 [17072344.001]
  • [Cites] Science. 2007 Apr 27;316(5824):608-11 [17463290.001]
  • [Cites] DNA Cell Biol. 2007 Apr;26(4):195-207 [17465886.001]
  • [Cites] Genomics. 2007 Jun;89(6):687-96 [17418524.001]
  • [Cites] Am J Pathol. 2007 Jun;170(6):1807-16 [17525249.001]
  • [Cites] J Mol Cell Cardiol. 2007 Jun;42(6):1137-41 [17498736.001]
  • [Cites] Circ Res. 2007 Jun 8;100(11):1579-88 [17478730.001]
  • [Cites] Nat Cell Biol. 2007 Jul;9(7):775-87 [17589498.001]
  • [Cites] Circ Res. 2007 Jul 6;101(1):59-68 [17540974.001]
  • [Cites] Mol Cell. 2007 Jul 6;27(1):91-105 [17612493.001]
  • [Cites] Biochem Soc Trans. 2007 Aug;35(Pt 4):661-4 [17635115.001]
  • [Cites] Cancer Res. 2007 Aug 15;67(16):7713-22 [17699775.001]
  • [Cites] Genes Dev. 2007 Aug 15;21(16):1999-2004 [17626790.001]
  • [Cites] Best Pract Res Clin Haematol. 2007 Sep;20(3):425-37 [17707831.001]
  • [Cites] PLoS Genet. 2007 Aug;3(8):e146 [17784791.001]
  • [Cites] J Cell Biochem. 2007 Oct 15;102(3):593-608 [17729308.001]
  • [Cites] J Immunol. 2007 Oct 15;179(8):5082-9 [17911593.001]
  • [Cites] Reprod Biol Endocrinol. 2007;5:35 [17718906.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Nov;8(11):857-69 [17895899.001]
  • [Cites] Nat Rev Cancer. 2007 Nov;7(11):819-22 [17914404.001]
  • [Cites] Reprod Biol Endocrinol. 2007;5:34 [17716379.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Jan;47(1):56-63 [17943974.001]
  • [Cites] Endocrinology. 2005 Mar;146(3):1074-96 [15604208.001]
  • [Cites] Endocrinology. 2005 Mar;146(3):1097-118 [15604209.001]
  • [Cites] Obstet Gynecol. 2005 Mar;105(3):563-8 [15738025.001]
  • [Cites] Semin Immunol. 2005 Apr;17(2):155-65 [15737576.001]
  • [Cites] PLoS Biol. 2005 Mar;3(3):e85 [15723116.001]
  • [Cites] Endocr Rev. 2005 May;26(3):423-38 [15857972.001]
  • [Cites] Science. 2005 Jun 10;308(5728):1589-92 [15947177.001]
  • [Cites] Mol Hum Reprod. 2005 Jul;11(7):489-94 [16123076.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9 [16166262.001]
  • [Cites] Hum Reprod. 2006 Jan;21(1):57-67 [16172143.001]
  • [Cites] J Soc Gynecol Investig. 2006 Feb;13(2):136-44 [16443508.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 [16461460.001]
  • [Cites] Obstet Gynecol Clin North Am. 2006 Mar;33(1):13-39 [16504804.001]
  • [Cites] Nat Cell Biol. 2006 Mar;8(3):278-84 [16489342.001]
  • [Cites] Nucleic Acids Res. 2006;34(6):1765-71 [16582102.001]
  • [Cites] Fertil Steril. 2006 Feb;85(2):462-7 [16595228.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 May 2;103(18):7024-9 [16641092.001]
  • [Cites] Mol Hum Reprod. 2006 Apr;12(4):245-56 [16571622.001]
  • [Cites] Hum Reprod. 2006 Jun;21(6):1380-6 [16488906.001]
  • [Cites] Gastroenterology. 2006 Jun;130(7):2113-29 [16762633.001]
  • [Cites] Cancer Res. 2006 Jun 15;66(12):6097-104 [16778182.001]
  • [Cites] Hum Reprod Update. 2006 Jul-Aug;12(4):385-400 [16603566.001]
  • [Cites] Hum Reprod. 2006 Sep;21(9):2408-16 [16720624.001]
  • [Cites] J Biol Chem. 2007 Mar 16;282(11):8256-64 [17220301.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3432-7 [17360662.001]
  • [Cites] Genes Dev. 2007 Mar 15;21(6):682-93 [17369401.001]
  • [Cites] Cell. 2007 Apr 6;129(1):147-61 [17382377.001]
  • [Cites] Fertil Steril. 2007 Apr;87(4):725-36 [17430732.001]
  • [Cites] Cancer Res. 2007 Nov 15;67(22):11001-11 [18006846.001]
  • [Cites] Dev Dyn. 2007 Dec;236(12):3321-31 [17685479.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Dec;8(12):970-82 [18000526.001]
  • [Cites] Mol Cancer. 2007;6:60 [17894887.001]
  • [Cites] Oncogene. 2007 Nov 29;26(54):7590-5 [17563749.001]
  • [Cites] Cancer Res. 2007 Dec 1;67(23):11099-101 [18056431.001]
  • [Cites] Stem Cell Rev. 2007 Dec;3(4):249-55 [17955391.001]
  • [Cites] Reprod Sci. 2007 Dec;14(8 Suppl):20-7 [18089606.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20350-5 [18077375.001]
  • [Cites] Trends Pharmacol Sci. 2008 Jan;29(1):12-5 [18068232.001]
  • [Cites] Oncogene. 2008 Jan 10;27(3):378-86 [17621267.001]
  • [Cites] Nat Rev Immunol. 2008 Feb;8(2):120-30 [18204468.001]
  • [Cites] Curr Stem Cell Res Ther. 2007 Dec;2(4):264-71 [18220910.001]
  • (PMID = 18951332.001).
  • [ISSN] 1526-4564
  • [Journal-full-title] Seminars in reproductive medicine
  • [ISO-abbreviation] Semin. Reprod. Med.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD037432-08; United States / NICHD NIH HHS / HD / R01 HD037432; United States / NICHD NIH HHS / HD / HD37432; United States / NICHD NIH HHS / HD / R01 HD037432-08
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gonadal Steroid Hormones; 0 / MicroRNAs
  • [Number-of-references] 117
  • [Other-IDs] NLM/ NIHMS121237; NLM/ PMC2710997
  •  go-up   go-down


14. Skubitz KM, Manivel JC: Giant cell tumor of the uterus: case report and response to chemotherapy. BMC Cancer; 2007;7:46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant cell tumor of the uterus: case report and response to chemotherapy.
  • BACKGROUND: Giant cell tumor (GCT) is usually a benign but locally aggressive primary bone neoplasm in which monocytic macrophage/osteoclast precursor cells and multinucleated osteoclast-like giant cells infiltrate the tumor.
  • The etiology of GCT is unknown, however the tumor cells of GCT have been reported to produce chemoattractants that can attract osteoclasts and osteoclast precursors.
  • CASE PRESENTATION: We report a case of an aggressive GCT of the uterus with rapidly growing lung metastases, and its response to chemotherapy with pegylated-liposomal doxorubicin, ifosfamide, and bevacizumab, along with a review of the literature.
  • CONCLUSION: Aggressive metastasizing GCT may arise in the uterus, and may respond to combination chemotherapy.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Giant Cell Tumors / drug therapy. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Angiogenesis Inhibitors / administration & dosage. Antibiotics, Antineoplastic / administration & dosage. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Humanized. Antineoplastic Agents, Alkylating / administration & dosage. Bevacizumab. Combined Modality Therapy. Doxorubicin / administration & dosage. Female. Humans. Hysterectomy. Ifosfamide / administration & dosage. Lung Neoplasms / diagnosis. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1992 Feb;158(2):331-4 [1729794.001]
  • [Cites] APMIS Suppl. 1991;23:113-8 [1883635.001]
  • [Cites] Cancer. 1993 Nov 15;72(10):2963-9 [8221562.001]
  • [Cites] Clin Orthop Relat Res. 1994 May;(302):219-30 [8168305.001]
  • [Cites] Am J Clin Oncol. 1995 Apr;18(2):144-8 [7900706.001]
  • [Cites] Pathol Int. 1996 Sep;46(9):656-60 [8905874.001]
  • [Cites] Clin Orthop Relat Res. 1997 Feb;(335):253-61 [9020226.001]
  • [Cites] J Clin Oncol. 1997 Jun;15(6):2378-84 [9196153.001]
  • [Cites] Cell. 1998 Apr 17;93(2):165-76 [9568710.001]
  • [Cites] Surg Neurol. 1998 May;49(5):547-52 [9586934.001]
  • [Cites] J Cell Biochem. 1998 Jul 1;70(1):121-9 [9632113.001]
  • [Cites] J Clin Oncol. 1998 Jul;16(7):2445-51 [9667262.001]
  • [Cites] Int Orthop. 1998;22(3):200-4 [9728318.001]
  • [Cites] Pediatrics. 1999 Jun;103(6 Pt 1):1282-3 [10353942.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1999 Jun;85(3):293-6 [10422135.001]
  • [Cites] J Exp Med. 1999 Jul 19;190(2):293-8 [10432291.001]
  • [Cites] J Cancer Res Clin Oncol. 1999 Oct;125(10):577-81 [10473871.001]
  • [Cites] Cancer. 2005 Jul 15;104(2):361-6 [15948172.001]
  • [Cites] J Clin Oncol. 2001 Aug 1;19(15):3483-9 [11481354.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):210-6 [11863217.001]
  • [Cites] Cancer. 2002 Jun 15;94(12):3225-9 [12115355.001]
  • [Cites] Clin Orthop Relat Res. 2002 Aug;(401):202-8 [12151897.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Oct;60(10):1103-11; discussion 1111-3 [12378481.001]
  • [Cites] Cancer Invest. 2003 Apr;21(2):167-76 [12743981.001]
  • [Cites] Life Sci. 2003 Aug 1;73(11):1427-36 [12850503.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):158-65 [12909228.001]
  • [Cites] Br J Surg. 2004 Feb;91(2):242-7 [14760675.001]
  • [Cites] Orthopade. 2004 Mar;33(3):344-8 [15007559.001]
  • [Cites] Skeletal Radiol. 2004 May;33(5):295-9 [14997349.001]
  • [Cites] J Lab Clin Med. 2004 Aug;144(2):78-91 [15322502.001]
  • [Cites] Clin Orthop Relat Res. 2004 Sep;(426):32-8 [15346048.001]
  • [Cites] Clin Orthop Relat Res. 2004 Sep;(426):103-9 [15346059.001]
  • [Cites] Clin Cancer Res. 2004 Sep 1;10(17):5732-40 [15355900.001]
  • [Cites] Calcif Tissue Int. 2004 Jul;75(1):71-7 [15037971.001]
  • [Cites] J Lab Clin Med. 2004 Oct;144(4):193-200 [15514587.001]
  • [Cites] Cancer. 1968 Aug;22(2):333-44 [5660199.001]
  • [Cites] Endocrinology. 1972 Oct;91(4):916-20 [5051344.001]
  • [Cites] Cancer. 1973 Mar;31(3):621-5 [4693590.001]
  • [Cites] Cancer. 1975 Aug;36(2):495-504 [50874.001]
  • [Cites] Science. 1975 Nov 21;190(4216):784-5 [1105786.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1976 Sep 21;371(3):199-217 [184582.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1981 Mar;89(2):179-84 [7270164.001]
  • [Cites] Cancer. 1981 Nov 1;48(9):2022-8 [7296510.001]
  • [Cites] Arkh Patol. 1983;45(2):78-82 [6847417.001]
  • [Cites] J Bone Joint Surg Am. 1985 Jul;67(6):890-900 [4019539.001]
  • [Cites] Nature. 1999 Nov 18;402(6759):304-9 [10580503.001]
  • [Cites] Am J Pathol. 2000 Mar;156(3):761-7 [10702390.001]
  • [Cites] J Bone Miner Res. 2000 Apr;15(4):640-9 [10780856.001]
  • [Cites] Hum Pathol. 2000 Jul;31(7):804-12 [10923916.001]
  • [Cites] Eur J Cancer. 2001 May;37(7):870-7 [11313175.001]
  • [Cites] J Pathol. 1985 Nov;147(3):153-8 [4067733.001]
  • [Cites] Gynecol Oncol. 1986 Mar;23(3):381-6 [3957125.001]
  • [Cites] J Clin Invest. 1987 Feb;79(2):483-91 [3027126.001]
  • [Cites] Clin Orthop Relat Res. 1988 Dec;(237):275-85 [3056645.001]
  • [Cites] Clin Orthop Relat Res. 1989 Jun;(243):208-15 [2656024.001]
  • [Cites] Cancer. 1990 Apr 15;65(8):1838-42 [2317762.001]
  • [Cites] J Cancer Res Clin Oncol. 1993;119(5):301-3 [8440744.001]
  • (PMID = 17359524.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibiotics, Antineoplastic; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antineoplastic Agents, Alkylating; 2S9ZZM9Q9V / Bevacizumab; 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  • [Number-of-references] 57
  • [Other-IDs] NLM/ PMC1832205
  •  go-up   go-down


15. Han XY, Xiang Y, Guo LN, Sheng K, Wan XR, Huang HF, Pan LY: [Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases]. Zhonghua Zhong Liu Za Zhi; 2010 Jan;32(1):44-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
  • OBJECTIVE: To investigate the clinicopathologic features, diagnosis, treatment and prognosis of uterine mullerian adenosarcoma.
  • METHODS: The clinicopathological data of 9 cases of uterine mullerian adenosarcoma in PUMC hospital from January 2003 to February 2009 were retrospectively analyzed.
  • RESULTS: There were 6 uterine endometrial adenosarcomas and 3 cervical adenosarcomas.
  • Physical examination showed cervical/vaginal mass, enlarged uterus or pelvic mass.
  • The adenosarcoma was characterized by benign or atypical-appearing neoplastic glands within a sarcomatous stroma.
  • During the follow-up, 2 cases of uterine endometrial adenosarcoma recurred.
  • The other one recurred 2 years after local excision of the tumor in the uterine cavity and she remained healthy since hysterectomy.
  • CONCLUSION: Uterine mullerian adenosarcoma is a rare tumor without specific clinical symptoms and signs.
  • The diagnosis depends on pathomorphologic examination.
  • The tumors show low malignant potential and the vast majority are at early stage.
  • Surgical excision is the main treatment strategy with a good prognosis in the early stage disease with complete removal of tumors.
  • [MeSH-major] Endometrial Neoplasms / pathology. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Adenosarcoma / drug therapy. Adenosarcoma / pathology. Adenosarcoma / surgery. Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Cisplatin / therapeutic use. Etoposide / therapeutic use. Female. Follow-Up Studies. Humans. Hysterectomy / methods. Ifosfamide / therapeutic use. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging. Retrospective Studies. Uterine Neoplasms / drug therapy. Uterine Neoplasms / pathology. Uterine Neoplasms / surgery. Young Adult

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20211067.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin; UM20QQM95Y / Ifosfamide; Adenosarcoma of the uterus; ICE protocol 1
  •  go-up   go-down


16. Grammatikakis I, Ivanov S, Evangelinakis N, Zevoudis S, Tziortzioti V: [Incidence of synchronous primary neoplasms of the female reproductive tract in women with ovarian endometriosis: a retrospective analysis of 811 cases]. Akush Ginekol (Sofiia); 2009;48(3):26-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Incidence of synchronous primary neoplasms of the female reproductive tract in women with ovarian endometriosis: a retrospective analysis of 811 cases].
  • PURPOSE: Although endometriosis is a benign disorder recent studies suggest endometriosis could be viewed as a neoplastic process.
  • Objective of this study is to explore the epidemiology of synchronous neoplasms (SPN) in women with severe endometriosis.
  • The medical records and pathology were reviewed to confirm the diagnosis and stage of tumors.
  • All of our patients had a grade-I endometrioid carcinoma of the uterus (Ia in 3, Ib in 2).
  • Median diameter of the ovarian neoplasias was 4.3 cm, in contradiction to 4.5 cm that was the median diameter of all endometrioid cysts.
  • [MeSH-major] Carcinoma, Endometrioid / epidemiology. Endometriosis / epidemiology. Neoplasms, Multiple Primary / epidemiology. Ovarian Neoplasms / epidemiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Bulgaria / epidemiology. Female. Greece / epidemiology. Humans. Incidence. Middle Aged. Neoplasm Staging. Retrospective Studies. Uterine Neoplasms / epidemiology. Uterine Neoplasms / pathology. Young Adult

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20198760.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


17. Tomsová M, Pohnĕtalová D, Spacek J: [Rare tumours of myometrium--intravenous leiomyomatosis and benign metastatic leiomyoma]. Ceska Gynekol; 2007 Apr;72(2):136-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rare tumours of myometrium--intravenous leiomyomatosis and benign metastatic leiomyoma].
  • Leiomyomas are the most common benign uterine neoplasms of the myometrium.
  • We present a case of intravenous leiomyomatosis in a 52-year-old woman and a case of benign metastasizing leiomyoma in a 45-year-old woman.
  • Intravenous leiomyomatosis is an uncommon condition in which morphologically benign smooth muscle is present within the lumina of the veins.
  • Benign metastasizing leiomyoma is a very rare phenomenon where histologically benign smooth muscle tumours are present at distant sites, particularly in the lungs, in women having histologically benign uterine leiomyoma.


18. Kitajima K, Murakami K, Kaji Y, Sugimura K: Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol; 2010 Sep;195(3):737-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spectrum of FDG PET/CT findings of uterine tumors.
  • OBJECTIVE: The purpose of this article is to review FDG PET/CT and MRI findings in a variety of benign and malignant tumors of the uterus and to become familiar with the wide variety of FDG PET/CT findings of this entity.
  • CONCLUSION: Benign uterine tumors generally have mild FDG uptake, and leiomyoma rarely shows high uptake.
  • Uterine malignant tumors generally have intense FDG uptake, whereas malignant uterine tumors that are small or that have low cellular density often show minimal uptake.
  • [MeSH-major] Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods. Uterine Neoplasms / radiography. Uterine Neoplasms / radionuclide imaging
  • [MeSH-minor] Endometrial Neoplasms / radiography. Endometrial Neoplasms / radionuclide imaging. Female. Fluorodeoxyglucose F18. Humans. Leiomyoma / radiography. Leiomyoma / radionuclide imaging. Magnetic Resonance Imaging. Precancerous Conditions / radiography. Precancerous Conditions / radionuclide imaging. Radiopharmaceuticals. Sarcoma / radiography. Sarcoma / radionuclide imaging

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20729454.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Number-of-references] 14
  •  go-up   go-down


19. Agdi M, Tulandi T: Minimally invasive approach for myomectomy. Semin Reprod Med; 2010 May;28(3):228-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine fibroids are the most common benign tumor of the uterus in women of reproductive age.
  • In those with abnormal uterine bleeding, one should exclude other causes of abnormal vaginal bleeding including endometrial cancer.
  • Diagnosis of uterine fibroid is established by pelvic ultrasonography with or without saline infusion hysterosonography.
  • Intramural and subserous myomas in women who opt for nonsurgical treatment could be treated with uterine artery embolization (UAE), high-intensity focused ultrasound (HIFU), or medical treatment such as selective gonadotropin-releasing hormone agonists, progesterone receptor modulators, or aromatase inhibitors.
  • [MeSH-major] Leiomyoma / surgery. Minimally Invasive Surgical Procedures. Uterine Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Thieme Medical Publishers.
  • (PMID = 20414845.001).
  • [ISSN] 1526-4564
  • [Journal-full-title] Seminars in reproductive medicine
  • [ISO-abbreviation] Semin. Reprod. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 58
  •  go-up   go-down


20. Czernobilsky B: Uterine tumors resembling ovarian sex cord tumors: an update. Int J Gynecol Pathol; 2008 Apr;27(2):229-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine tumors resembling ovarian sex cord tumors: an update.
  • Tumors of the uterus resembling ovarian sex cord tumors were reported by Clement and Scully in 1976 and were divided in 2 groups: group 1, endometrial stromal tumors, and group 2, mural uterine tumors-both with elements resembling ovarian sex cord tumors.
  • In the former, the sex cord component constitutes a minor portion of an endometrial stromal neoplasm, whereas in the latter, it is the predominant or exclusive component of a uterine wall lesion composed of a variety of mesenchymal elements.
  • An origin from endometrial stromal cells, adenomyosis, stromal myosis, endometriosis, or multipotential cells within the myometrium was postulated in both groups of tumors.
  • In group 1 tumors, the prognosis depends on the type, grade, and stage of the underlying stromal neoplasm.
  • Group 2 tumors seemed to be benign, although because of the occasional recurrence of these tumors, they should be considered of low-grade malignant potential.
  • In group 1 tumors, the sex cord elements remained limited to cords, trabeculae, nests, and tubules.
  • Eventually, the abbreviation ESTSCLE, or endometrial stromal tumors with sex cord-like elements, was given to group 1 tumors, whereas UTROSCT, or uterine tumor resembling ovarian sex cord tumor, was used for group 2 tumors.
  • Positivity for calretinin and at least for 1 of the other above-mentioned markers may thus confirm the diagnosis of UTROSCT.
  • Endometrial stromal tumors with sex cord-like elements, on the other hand, usually express only 1 sex cord marker, mostly calretinin.
  • In conclusion, UTROSCT and, to a lesser degree, ESTSCLE, are polyphenotypic neoplasms, which, according to the evidence available at present, most likely arise from pluripotential uterine mesenchymal cells.
  • [MeSH-major] Ovarian Neoplasms / pathology. Sex Cord-Gonadal Stromal Tumors / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Cell Differentiation. Diagnosis, Differential. Endometrial Stromal Tumors / diagnosis. Endometrial Stromal Tumors / pathology. Female. Humans

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18317219.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 40
  •  go-up   go-down


21. Biermann K, Heukamp LC, Büttner R, Zhou H: Uterine tumor resembling an ovarian sex cord tumor associated with metastasis. Int J Gynecol Pathol; 2008 Jan;27(1):58-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine tumor resembling an ovarian sex cord tumor associated with metastasis.
  • Uterine tumors resembling ovarian sex-cord tumors (UTROSCT) are very rare, usually benign uterine tumors, and are probably derived from uterine mesenchymal stem cells.
  • Four years after a diagnosis of UTROSCT of the uterine corpus, the patient developed obstructive ileus due to a large infiltrating tumor within the small bowel with the same morphology and expression pattern as the previously diagnosed UTROSCT.
  • In addition, 2 benign gastrointestinal stromal tumors were detected in the same patient.
  • This case indicates that although the majority of UTROSCT are benign tumors, some of them might undergo malignant transformation and have a metastatic potency.
  • [MeSH-major] Intestinal Neoplasms / secondary. Ovarian Neoplasms / pathology. Sex Cord-Gonadal Stromal Tumors / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Aged. Biomarkers, Tumor / analysis. Female. Gastrointestinal Stromal Tumors / metabolism. Gastrointestinal Stromal Tumors / pathology. Humans. Immunohistochemistry. Intestinal Obstruction / etiology. Intestine, Small / metabolism. Intestine, Small / pathology. Neoplasms, Second Primary / metabolism. Neoplasms, Second Primary / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18156976.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


22. Deen S, Duncan TJ, Hammond RH: Malignant female adnexal tumors of probable Wolffian origin. Int J Gynecol Pathol; 2007 Oct;26(4):383-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant female adnexal tumors of probable Wolffian origin.
  • Female adnexal tumors of probable Wolffian origin are rare.
  • Although the histological features of the benign tumors are recognized, features of malignancy are not well defined in published work because these tumors are particularly rare.
  • A pelvic transvaginal ultrasound scan demonstrated a midline, highly vascular, predominantly solid pelvic mass, approximately 14 cm, posterior to the uterus.
  • Immunohistochemical staining and electron microscopy supported the diagnosis of female adnexal tumor of probable Wolffian origin.
  • There was significant and widespread nuclear pleomorphism with increased mitotic activity endorsing the diagnosis of a malignant tumor.
  • [MeSH-minor] Aged, 80 and over. Female. Humans. Hysterectomy. Neoplasm Recurrence, Local / pathology. Uterine Hemorrhage / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17885487.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Mangioni S, Viganò P, Lattuada D, Abbiati A, Vignali M, Di Blasio AM: Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor. J Clin Endocrinol Metab; 2005 Sep;90(9):5349-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor.
  • CONTEXT: Uterine leiomyomas are the most common tumors in the human female pelvis and the leading indication for pelvic surgery.
  • Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
  • [MeSH-major] Leiomyoma / metabolism. Proto-Oncogene Proteins / metabolism. Signal Transduction. Uterine Neoplasms / metabolism

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15972578.001).
  • [ISSN] 0021-972X
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 0 / Proto-Oncogene Proteins; 0 / RNA, Messenger; 0 / SFRP1 protein, human; 0 / WNT5B protein, human; 0 / Wnt Proteins
  •  go-up   go-down


24. Mesquita FS, Dyer SN, Heinrich DA, Bulun SE, Marsh EE, Nowak RA: Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol Reprod; 2010 Feb;82(2):341-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine leiomyomas are benign uterine tumors characterized by extracellular matrix remodeling, increased collagen deposition, and increased smooth muscle cell (SMC) proliferation.
  • The necessity of NADPH oxidase-derived ROS for EGF and PDGF signaling pathways leading to cell proliferation points to another potential therapeutic target for treatment and/or prevention of uterine leiomyomas.
  • [MeSH-major] Epidermal Growth Factor / pharmacology. Leiomyoma / metabolism. Platelet-Derived Growth Factor / pharmacology. Reactive Oxygen Species / metabolism. Signal Transduction / physiology. Uterine Neoplasms / metabolism
  • [MeSH-minor] Cell Division / drug effects. Cell Line, Tumor. DNA / biosynthesis. Enzyme Activation / drug effects. Enzyme Inhibitors / pharmacology. Female. Humans. Hydrogen Peroxide / pharmacology. Mitogen-Activated Protein Kinases / metabolism. Muscle, Smooth / metabolism. NADPH Oxidase / antagonists & inhibitors


25. Bodner-Adler B, Bartl M, Wagner G: Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma? Anticancer Res; 2009 Feb;29(2):495-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
  • BACKGROUND: Intravenous leiomyomatosis (IVL) is defined as an intraluminal growth of benign smooth muscle cells in either venous or lymphatic vessels outside the confines or even in the absence of leiomyomas.
  • Benign metastasizing uterine leiomyoma is defined as a histologically benign uterine smooth muscle tumor that acts in a somewhat malignant fashion and produces benign metastases.
  • We report a case of a patient suffering from IVL of the uterus and pulmonary leiomyomatosis.
  • CASE REPORT: The patient presented with severe hypermenorrhoe and a rapidly growing uterine fibroid.
  • An open lung biopsy led to the diagnosis of pulmonary leiomyomatosis.
  • CONCLUSION: Though intravenous leiomyomatosis imitates a malignant neoplasm concerning the pattern of growth and extension, and benign metastasizing leiomyoma produces benign metastases, they must be differentiated histologically from malignant tumors to prevent overtreatment.
  • [MeSH-major] Leiomyoma / pathology. Leiomyomatosis / pathology. Lung Neoplasms / secondary. Uterine Neoplasms / pathology. Vascular Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans


26. Yasmeen F, Hafeez M, Hameed S, Saeed A, Ibnerasa SN: Symplastic leiomyoma of uterus: a rare histological variant. J Coll Physicians Surg Pak; 2008 May;18(5):308-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Symplastic leiomyoma of uterus: a rare histological variant.
  • The patient was managed as for a benign tumor.
  • [MeSH-major] Leiomyoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Hysterectomy. Neoplasm Staging. Severity of Illness Index

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18541089.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


27. Haberal A, Cil AP, Gunes M, Cavusoglu D: Papillary adenofibroma of the cervix: a case report. Ultrasound Obstet Gynecol; 2005 Aug;26(2):186-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenofibroma is an extremely rare benign biphasic neoplasm that is classified into the mixed epithelial and mesenchymal tumor group.
  • Preoperative diagnosis of this tumor is usually difficult.
  • This lesion appears to be clinically and histologically benign but must be differentiated from malignant lesions of the uterus, particularly from adenosarcoma, which can be suggestive of adenofibroma.
  • Accurate diagnosis of these benign tumors permits appropriate counseling of patients.
  • [MeSH-major] Adenofibroma / ultrasonography. Uterine Cervical Neoplasms / ultrasonography


28. Takeuchi M, Matsuzaki K, Uehara H, Yoshida S, Nishitani H, Shimazu H: Pathologies of the uterine endometrial cavity: usual and unusual manifestations and pitfalls on magnetic resonance imaging. Eur Radiol; 2005 Nov;15(11):2244-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pathologies of the uterine endometrial cavity: usual and unusual manifestations and pitfalls on magnetic resonance imaging.
  • The endometrial cavity may demonstrate various imaging manifestations such as normal, reactive, inflammatory, and benign and malignant neoplasms.
  • We evaluated usual and unusual magnetic resonance imaging (MRI) findings of the uterine endometrial cavity, and described the diagnostic clues to differential diagnoses.
  • Surgically proven pathologies of the uterine endometrial cavity were evaluated retrospectively with pathologic correlation.
  • The pathologies included benign endometrial neoplasms such as endometrial hyperplasia and polyp, malignant endometrial neoplasms such as endometrial carcinoma and carcinosarcoma, endometrial-myometrial neoplasm such as endometrial stromal sarcoma, pregnancy-related lesions in the endometrial cavity such as gestational trophoblastic diseases (hydatidiform mole, invasive mole and choriocarcinoma) and placental polyp, myometrial lesions simulating endometrial lesions such as submucosal leiomyoma and some adenomyosis, endometrial neoplasms simulating myometrial lesions such as adenomyomatous polyp and endometrial lesions arising in the hemicavity of a septate/bicornate uterus, and fluid collections in the uterine cavity (hydro/hemato/pyometra).
  • It is important to recognize various imaging findings in these diseases, in order to make a correct preoperative diagnosis.
  • [MeSH-major] Endometrial Neoplasms / diagnosis. Endometrium / pathology. Magnetic Resonance Imaging. Uterine Diseases / diagnosis

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Uterine Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1999 Sep;173(3):767-72 [10470920.001]
  • [Cites] Radiology. 2000 Jan;214(1):47-52 [10644100.001]
  • [Cites] Radiology. 1993 Jan;186(1):163-8 [7677973.001]
  • [Cites] Radiographics. 1999 Oct;19 Spec No:S131-45 [10517450.001]
  • [Cites] Radiographics. 1996 Nov;16(6):1371-84 [8946542.001]
  • [Cites] Comput Med Imaging Graph. 1995 Jul-Aug;19(4):351-5 [8653672.001]
  • [Cites] Radiology. 1993 Feb;186(2):495-501 [8421757.001]
  • [Cites] Radiology. 1992 Oct;185(1):207-12 [1523309.001]
  • [Cites] Eur Radiol. 2004 Jun;14(6):945-52 [15045519.001]
  • [Cites] Radiographics. 1996 Jan;16(1):131-48 [10946695.001]
  • [Cites] AJR Am J Roentgenol. 1991 Dec;157(6):1221-3 [1950869.001]
  • [Cites] Eur Radiol. 2003 Aug;13(8):2038-45 [12942305.001]
  • [Cites] Invest Radiol. 1996 Aug;31(8):492-6 [8854195.001]
  • [Cites] AJR Am J Roentgenol. 1989 Aug;153(2):317-9 [2546411.001]
  • [Cites] J Comput Assist Tomogr. 1995 May-Jun;19(3):444-8 [7790556.001]
  • [Cites] Eur Radiol. 2001;11(1):28-33 [11194912.001]
  • [Cites] J Comput Assist Tomogr. 1996 Nov-Dec;20(6):878-87 [8933785.001]
  • [Cites] Radiology. 2000 Jan;214(1):29-38 [10644098.001]
  • [Cites] Magn Reson Imaging. 1999 Dec;17(10):1445-55 [10609993.001]
  • [Cites] AJR Am J Roentgenol. 2001 Dec;177(6):1307-11 [11717072.001]
  • [Cites] Radiographics. 1999 Oct;19 Spec No:S147-60 [10517451.001]
  • [Cites] Eur Radiol. 2000;10 (5):776-9 [10823632.001]
  • (PMID = 16228215.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


29. Lax S: [Mesenchymal uterine tumors. Stromal tumors and other rare mesenchymal neoplasms]. Pathologe; 2009 Jul;30(4):284-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Mesenchymal uterine tumors. Stromal tumors and other rare mesenchymal neoplasms].
  • Uterine stromal neoplasms are classified into endometrial stromal nodules and stromal sarcomas, as well as undifferentiated sarcomas.
  • Stromal tumors are distinct from stromal nodules by virtue of their myometrial and vascular invasion.
  • Adenosarcomas are mixed neoplasms with a low grade stromal sarcoma component containing benign glands, which are surrounded by condensed neoplastic stroma.
  • Typical uterine tumors resembling ovarian sex cord tumors (UTROSCT Type2) show predominant sex cord differentiation in a well circumscribed nodule.
  • [MeSH-major] Endometrial Stromal Tumors / pathology. Ovarian Neoplasms / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Arterioles / pathology. Cell Differentiation. Cell Nucleus / pathology. Cytoplasm / pathology. Diagnosis, Differential. Female. Humans. Muscle, Skeletal / pathology. Muscle, Smooth / pathology. Neoplasm Invasiveness. Neoplasm Metastasis. Sarcoma / pathology. Sex Cord-Gonadal Stromal Tumors / pathology. Uterus / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2007 Oct;60(10):1148-54 [17182656.001]
  • [Cites] Am J Clin Pathol. 1976 Sep;66(3):512-25 [961630.001]
  • [Cites] J Mol Diagn. 2005 Aug;7(3):388-95 [16049311.001]
  • [Cites] Virchows Arch. 2004 May;444(5):410-4 [15007645.001]
  • [Cites] Am J Surg Pathol. 1995 Jul;19(7):757-68 [7793473.001]
  • [Cites] Int J Gynecol Pathol. 2008 Apr;27(2):229-35 [18317219.001]
  • [Cites] Histopathology. 1981 Jan;5(1):1-10 [7216172.001]
  • [Cites] Adv Anat Pathol. 2004 May;11(3):162-71 [15096730.001]
  • [Cites] J Clin Pathol. 2007 Mar;60(3):235-43 [17347285.001]
  • [Cites] Am J Surg Pathol. 2008 Aug;32(8):1228-38 [18580489.001]
  • [Cites] Am J Surg Pathol. 1998 Aug;22(8):997-1005 [9706980.001]
  • [Cites] Histopathology. 2009 Feb;54(3):355-64 [19236512.001]
  • [Cites] Int J Gynaecol Obstet. 2009 Mar;104(3):177-8 [19135669.001]
  • [Cites] Adv Anat Pathol. 2004 Nov;11(6):310-5 [15505532.001]
  • [Cites] Int J Gynecol Cancer. 2005 Mar-Apr;15(2):337-42 [15823122.001]
  • [Cites] Pathology. 2007 Feb;39(1):46-54 [17365822.001]
  • [Cites] Am J Surg Pathol. 2009 Feb;33(2):278-88 [18941402.001]
  • (PMID = 19495764.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


30. Vilos GA, Hollett-Caines J, Abu-Rafea B, Allen HH, Inculet R, Kirk ME: Leiomyosarcoma diagnosed six years after laparoscopic electromyolysis. J Obstet Gynaecol Can; 2008 Jun;30(6):500-504
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Making a histologic diagnosis of leiomyosarcoma in the specimen from a hysterectomy performed for suspected benign fibroids is rare.
  • Currently, there are no reliable diagnostic tools to diagnose uterine sarcomas preoperatively.
  • CASE: A 38-year-old woman presented with menorrhagia and a uterine fibroid measuring 6.0 cm x 8.1 cm x 6.2 cm on ultrasonography.
  • Six years after myolysis, the patient presented with right lower quadrant pain and a rapidly enlarging uterus.
  • Hysterectomy and bilateral salpingo-oophorectomy was performed and a diagnosis of leiomyosarcoma was histologically confirmed.
  • CONCLUSION: The current trend in treatment for symptomatic fibroids is therapy sparing the uterus.
  • Women considering uterus-sparing treatment should be advised of the potential risk of uterine malignancy, even though that risk is quite minimal (< 0.5%).
  • A delay in the diagnosis of uterine malignancy may ultimately compromise long-term survival.
  • [MeSH-major] Leiomyosarcoma / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Hysterectomy. Laparoscopy. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Myometrium / surgery. Neoplasm Metastasis. Treatment Outcome

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18611301.001).
  • [ISSN] 1701-2163
  • [Journal-full-title] Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
  • [ISO-abbreviation] J Obstet Gynaecol Can
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


31. Stübinger SH, van der Horst Ch, Braun PM: [Pelvic tumors in the eyes of urologists]. Ther Umsch; 2007 Jul;64(7):395-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pelvic tumors in the eyes of urologists].
  • [Transliterated title] Raumforderungen im kleinen Becken aus Sicht des Urologen.
  • Pelvic tumors originating from outside the urinary tract commonly invade the urogenital organs by direct extension mainly because of the close relationships between the pelvic organs.
  • Benign tumors such as endometrial myoma, ovarian cyst and adenoma of the colon might lead to the development of urogenital symptoms.
  • This is also the case with malignant tumors of the uterus, ovaries, cervix and colon where infiltration of the urogenital organs might be noted.
  • These are the symptoms that lead to the diagnosis of the primary tumor.
  • It has to be kept in mind that urogenital tumors with such symptoms have to be included in the differential diagnosis.
  • The possibility of eradicating the tumor is then to be discussed after relieving the obstruction.
  • [MeSH-major] Pelvic Neoplasms. Prostatic Hyperplasia. Prostatic Neoplasms. Urethral Neoplasms. Urinary Bladder Neoplasms
  • [MeSH-minor] Cystectomy. Cystoscopy. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Male. Neoplasm Staging. Prostatectomy. Quality of Life. Urinary Bladder / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17948757.001).
  • [ISSN] 0040-5930
  • [Journal-full-title] Therapeutische Umschau. Revue thérapeutique
  • [ISO-abbreviation] Ther Umsch
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


32. Canis M, Jardon K, Niro J, Rabischong B, Bourdel N, Botchorishvili R, Pouly JL, Mage G: [Endoscopic management of gynecological malignancies: an update. 2007]. Bull Acad Natl Med; 2007 Oct;191(7):1357-65; discussion 1365-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Coelioscopie et cancer en gynécologie: le point en 2007.
  • Animal studies suggest that the risk of tumor dissemination in the non traumatized peritoneum may be higher after pneumoperitoneum than after laparotomy, and they also show the importance of the surgeon's experience and technique.
  • By controlling these parameters we may, in future, be able to create a peritoneal environment suitable for oncologic indications and thereby prevent or minimize the risk of peritoneal dissemination and postoperative tumor growth.
  • In endometrial cancer, the laparoscopic approach should be reserved for clinical stage I disease, if the volume of the uterus and local conditions are appropriate for vaginal extraction.
  • Laparoscopy is the gold standard for surgical diagnosis of adnexal masses, but puncture should be avoided whenever possible.
  • In contrast, restaging of early ovarian cancer initially managed as a benign mass is a good indication for the laparoscopic approach.
  • Laparoscopic management of tumors with low malignant potential should include complete staging of the peritoneum.
  • [MeSH-major] Endoscopy / methods. Genital Neoplasms, Female / surgery. Gynecologic Surgical Procedures / methods
  • [MeSH-minor] Animals. Carcinoma / secondary. Carcinoma / surgery. Endometrial Neoplasms / surgery. Female. Humans. Neoplasm Seeding. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / pathology. Ovarian Neoplasms / surgery. Peritoneal Neoplasms / secondary. Pneumoperitoneum, Artificial / adverse effects. Pneumoperitoneum, Artificial / methods. Swine. Uterine Cervical Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18447057.001).
  • [ISSN] 0001-4079
  • [Journal-full-title] Bulletin de l'Académie nationale de médecine
  • [ISO-abbreviation] Bull. Acad. Natl. Med.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 30
  •  go-up   go-down


33. Saeed AS, Hanaa B, Faisal AS, Najla AM: Cotyledonoid dissecting leiomyoma of the uterus: a case report of a benign uterine tumor with sarcomalike gross appearance and review of literature. Int J Gynecol Pathol; 2006 Jul;25(3):262-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cotyledonoid dissecting leiomyoma of the uterus: a case report of a benign uterine tumor with sarcomalike gross appearance and review of literature.
  • Cotyledonoid dissecting leiomyoma (Sternberg tumor) is a very rare variant of uterine smooth muscle tumor with an unusual and alarming gross appearance.
  • A 41-cm fungating rubbery mass with placenta-like appearance adhering to the posterior uterine surface and extending to the left broad ligament and pelvic cavity was observed.
  • An intraoperative frozen section was requested, and a diagnosis of a benign smooth muscle tumor was given.
  • Total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed with removal of the pelvic tumor extension.
  • Thorough tumor sampling was performed and showed nodules of interlacing bundles of bland-looking smooth muscle cells, separated by expanded, edematous, and highly vascularized stroma.
  • Immunohistochemical studies confirmed the smooth muscle nature of the tumor.
  • [MeSH-major] Leiomyoma / pathology. Neoplasms / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Actins / analysis. Adult. Antigens, CD34 / analysis. Female. Frozen Sections. Humans. Proto-Oncogene Proteins c-kit / analysis. Receptors, Progesterone / analysis. Sarcoma / chemistry. Sarcoma / diagnosis. Sarcoma / pathology. Smooth Muscle Tumor / chemistry. Smooth Muscle Tumor / diagnosis. Smooth Muscle Tumor / pathology

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16810065.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD34; 0 / Receptors, Progesterone; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  • [Number-of-references] 13
  •  go-up   go-down


34. Yang YP, Zhu YL, Wu WP, Wang ZM, Zhang JM: [Perivascular epithelioid cell tumor of uterus: report of 5 cases and literature review]. Zhonghua Bing Li Xue Za Zhi; 2007 May;36(5):302-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Perivascular epithelioid cell tumor of uterus: report of 5 cases and literature review].
  • OBJECTIVE: To study the pathologic features, diagnosis, differential diagnosis and biologic behavior of uterine perivascular epithelioid tumor.
  • METHODS: Five cases of uterine perivascular epithelioid cell tumor were studied by light microscopy and immunohistochemistry.
  • RESULTS: All the five tumors were composed by clear or eosinophilic cells arranged in nests and cords, associated with abundant small vessels and hyalinization in the stroma.
  • Immunohistochemically, the tumor cells demonstrated positive staining for melanocytic markers (HMB45 and/or Melan-A), desmin and smooth muscle actin.
  • CONCLUSIONS: Perivascular epithelioid cell tumor is a rare mesenchymal tumor of uterus, with distinctive histologic and immunohistochemical features.
  • It should be distinguished from clear cell carcinoma and epithelioid leiomyoma of uterus.
  • Positivity for melanocytic markers (especially HMB45) plays an important role in the diagnosis of this tumor.
  • In general, the tumor is categorized as benign, with uncertain malignant potential and malignant.
  • [MeSH-major] Antigens, Neoplasm / metabolism. Neoplasm Proteins / metabolism. Perivascular Epithelioid Cell Neoplasms / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Clear Cell / pathology. Adult. Desmin / metabolism. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Hysterectomy / methods. Immunohistochemistry. Leiomyoma, Epithelioid / pathology. Melanoma-Specific Antigens. Middle Aged

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17706136.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Desmin; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins
  • [Number-of-references] 24
  •  go-up   go-down


35. Salomir R, Delemazure AS, Palussière J, Rouvière O, Cotton F, Chapelon JY: Image-based control of the magnetic resonance imaging-guided focused ultrasound thermotherapy. Top Magn Reson Imaging; 2006 Jun;17(3):139-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • (1) a versatile, nonionizing physical agent for therapy and (2) a state-of-the art diagnosis and on-line monitoring tool.
  • A commercially available, Food and Drug Administration-approved device using the MRI-guided FUS exists since 2004 for the ablation of benign tumors (uterine fibroids); however, the ultimate goal of the technological, methodological, and medical research in this field is to provide a clinical-routine tool for fighting localized cancer.
  • [MeSH-major] Brain Neoplasms / therapy. Breast Neoplasms / therapy. Kidney Neoplasms / therapy. Magnetic Resonance Imaging / methods. Prostatic Neoplasms / therapy. Ultrasonic Therapy / methods


36. Rachinsky I, Driedger A: Iodine-131 uptake in a menstruating uterus: value of SPECT/CT in distinguishing benign and metastatic iodine-positive lesions. Thyroid; 2007 Sep;17(9):901-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Iodine-131 uptake in a menstruating uterus: value of SPECT/CT in distinguishing benign and metastatic iodine-positive lesions.
  • [MeSH-major] Iodine / metabolism. Iodine Radioisotopes. Menstruation / physiology. Uterus / metabolism
  • [MeSH-minor] Adult. Carcinoma, Papillary / surgery. Female. Humans. Neoplasm Metastasis / diagnosis. Thyroid Neoplasms / surgery. Tomography, Emission-Computed, Single-Photon

  • MedlinePlus Health Information. consumer health - Menstruation.
  • Hazardous Substances Data Bank. IODINE, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17956166.001).
  • [ISSN] 1050-7256
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes; 9679TC07X4 / Iodine
  •  go-up   go-down


37. Shi Y, Liu Z, Peng Z, Liu H, Yang K, Yao X: The diagnosis and treatment of Mullerian adenosarcoma of the uterus. Aust N Z J Obstet Gynaecol; 2008 Dec;48(6):596-600
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The diagnosis and treatment of Mullerian adenosarcoma of the uterus.
  • BACKGROUND: Adenosarcoma of the uterus is one of the rare types of gynaecological malignant tumours.
  • Poor awareness of it among clinicians makes it difficult to diagnose correctly and timely, so it is helpful to enrich and update our knowledge about the tumour with new information of patients.
  • AIM: To improve the level of diagnosis and treatment of Mullerian adenosarcoma of the uterus.
  • METHODS: The medical data of nine patients with Mullerian adenosarcoma of the uterus who were treated from May 1995 to March 2006 in our hospital were analysed retrospectively.
  • RESULTS: Patients typically presented with abnormal uterine bleeding, pain in the lower abdomen, enlargement of the uterus, a mass in the uterine cavity and/or a cervical neoplasm.
  • Microscopically, the glands were lined by benign or atypical glandular epithelium, together with sarcomatous stromal cells which showed characteristic structures of 'periglandular cuff' of increased cellularity and 'intraglandular polypoid projections'.
  • The primary diagnostic rate was 33.3% and the average interval from symptom onset to final diagnosis was 13 months and eight weeks for pre- and postmenopausal patients, respectively.
  • CONCLUSIONS: The most common symptom of adenosarcoma of the uterus is abnormal uterine bleeding.
  • [MeSH-major] Adenosarcoma / diagnosis. Mixed Tumor, Mullerian / diagnosis. Neoplasms, Germ Cell and Embryonal / diagnosis. Uterine Cervical Neoplasms / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Age Factors. Diagnosis, Differential. Female. Humans. Middle Aged. Neoplasm Staging. Prognosis. Retrospective Studies. Treatment Outcome. Young Adult


38. Pan X, Dib HH, Zhu M, Zhang Y, Fan Y: Absence of appropriate hospitalization cost control for patients with medical insurance: a comparative analysis study. Health Econ; 2009 Oct;18(10):1146-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Expose the weak loops in the Chinese medical insurance coverage and uncover hospitals' role of over-pricing hospitalized insured patients compared with those non-insured.
  • METHODS: A multi-linear regression method was used to analyze hospitalization expense for insured and uninsured patients with uncomplicated acute appendicitis, cholecystitis, benign uterine tumors, and normal delivery.

  • MedlinePlus Health Information. consumer health - Health Insurance.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18972328.001).
  • [ISSN] 1099-1050
  • [Journal-full-title] Health economics
  • [ISO-abbreviation] Health Econ
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  •  go-up   go-down


39. Newsom-Davis T, Poulter D, Gray R, Ameen M, Lindsay I, Papanikolaou K, Butler-Manuel S, Christmas T, Townsend P, Seckl M: Case report: malignant teratoma of the uterine corpus. BMC Cancer; 2009;9:195
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case report: malignant teratoma of the uterine corpus.
  • Uterine teratomas are extremely rare with only a few previous case reports, usually involving mature teratomas of the uterine cervix.
  • Initial investigations revealed a benign teratoma of the uterus which was removed.
  • Her symptoms persisted and a recurrent, now malignant, teratoma of the uterine corpus was resected at hysterectomy.
  • CONCLUSION: In this report we discuss the aetiology, diagnosis and management of uterine teratomas, and review previous case studies.
  • [MeSH-major] Teratoma / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cisplatin / administration & dosage. Etoposide / administration & dosage. Female. Humans. Hysterectomy. Lymphatic Diseases / etiology. Lymphatic Metastasis. Neoplasm Metastasis. Treatment Outcome

  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Int. 2003 May;53(5):327-31 [12713570.001]
  • [Cites] Br J Cancer. 2004 Mar 22;90(6):1169-75 [15026797.001]
  • [Cites] Obstet Gynecol. 1972 Nov;40(5):686-91 [5083218.001]
  • [Cites] N Engl J Med. 1975 Jan 9;292(2):63-6 [162806.001]
  • [Cites] Histopathology. 1979 Jul;3(4):339-45 [468134.001]
  • [Cites] Gynecol Oncol. 1985 May;21(1):106-10 [3988122.001]
  • [Cites] Ann Oncol. 2008 Sep;19(9):1578-83 [18453518.001]
  • [Cites] Acta Obstet Gynecol Scand. 1998 Oct;77(9):936-8 [9808385.001]
  • [Cites] AJR Am J Roentgenol. 2005 Jul;185(1):216-8 [15972426.001]
  • [Cites] Ultrasound Obstet Gynecol. 2007 Apr;29(4):477-8 [17330830.001]
  • [Cites] Ann Diagn Pathol. 2007 Aug;11(4):293-6 [17630116.001]
  • [Cites] Obstet Gynecol. 2007 Aug;110(2 Pt 2):491-3 [17666639.001]
  • [Cites] Int J Gynecol Cancer. 2008 Jan-Feb;18(1):43-50 [17466047.001]
  • [Cites] Kurume Med J. 1993;40(3):153-8 [8139215.001]
  • (PMID = 19538751.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin
  • [Other-IDs] NLM/ PMC2709639
  •  go-up   go-down


40. Canis M, Farina M, Jardon K, Rabischong B, Rivoire C, Nohuz E, Botchorishvili R, Pouly JL, Mage G: [Laparoscopy and gynecologic cancer in 2005]. J Gynecol Obstet Biol Reprod (Paris); 2006 Apr;35(2):117-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Coelioscopie et cancer en gynécologie: le point en 2005.
  • Animal studies suggested that the risk of tumor dissemination in non traumatized peritoneum is higher after a pneumoperitoneum than after a laparotomy.
  • Changing these parameters we may, in the future, be able to create a peritoneal environment adapted to oncologic patients in order to prevent or to decrease the risks of peritoneal dissemination and/or of postoperative tumor growth.
  • In patients with endometrial cancer, the laparoscopic approach should be reserved to clinical stage I disease, if the vaginal extraction is anticipated to be easy accounting for the volume of the uterus and the local conditions.
  • Laparoscopy is the gold standard for the surgical diagnosis of adnexal masses.
  • In contrast restaging of an early ovarian cancer initially managed as a benign mass, is a good indication of the laparoscopic approach.
  • The laparoscopic management of low malignant potential tumors should include a complete staging of the peritoneum.
  • [MeSH-major] Genital Neoplasms, Female / surgery. Laparoscopy
  • [MeSH-minor] Animals. Endometrial Neoplasms / pathology. Endometrial Neoplasms / surgery. Female. Humans. Neoplasm Invasiveness. Neoplasm Metastasis. Neoplasm Staging. Ovarian Neoplasms / pathology. Ovarian Neoplasms / surgery. Peritoneal Neoplasms / epidemiology. Peritoneal Neoplasms / etiology. Pneumoperitoneum, Artificial / adverse effects. Risk Factors. Uterine Cervical Neoplasms / pathology. Uterine Cervical Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16575358.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 190
  •  go-up   go-down


41. Mavrelos D, Ben-Nagi J, Holland T, Hoo W, Naftalin J, Jurkovic D: The natural history of fibroids. Ultrasound Obstet Gynecol; 2010 Feb;35(2):238-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Fibroids are common, hormone-dependent, benign uterine tumors.
  • METHODS: This was a retrospective longitudinal study of premenopausal women who were diagnosed with uterine fibroids on ultrasound examination.
  • CONCLUSION: The growth of fibroids in premenopausal women is influenced by the tumor's size at presentation.
  • [MeSH-major] Leiomyomatosis / ultrasonography. Uterine Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Female. Humans. Longitudinal Studies. Middle Aged. Premenopause. Prognosis. Regression Analysis. Retrospective Studies. Risk Assessment. Treatment Outcome. Tumor Burden

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20069541.001).
  • [ISSN] 1469-0705
  • [Journal-full-title] Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • [ISO-abbreviation] Ultrasound Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


42. Tatebe S, Oka K, Kuraoka S, Yatabe Y: Benign metastasizing leiomyoma of the lung: potential role of low-grade malignancy. Thorac Cardiovasc Surg; 2009 Apr;57(3):180-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign metastasizing leiomyoma of the lung: potential role of low-grade malignancy.
  • We report here 2 cases of multiple metastatic lung tumors after hysterectomy for leiomyoma.
  • One patient was diagnosed as having a benign metastasizing leiomyoma (BML), while the other patient simultaneously developed a left pelvic tumor and multiple lung tumors, both of which were finally diagnosed as low-grade endometrial stromal sarcomas (ESSs).
  • The metastatic potential of BML is not completely understood, but previously reported cases of BML may include low-grade ESS, which may play a significant role in the metastasis of benign uterine tumors.
  • [MeSH-major] Endometrial Neoplasms / pathology. Leiomyomatosis / pathology. Lung Neoplasms / secondary. Pelvic Neoplasms / pathology. Sarcoma, Endometrial Stromal / secondary. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19330762.001).
  • [ISSN] 0171-6425
  • [Journal-full-title] The Thoracic and cardiovascular surgeon
  • [ISO-abbreviation] Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


43. Rathat G, Blanc PM, Guillon F, Millat B: [Intravascular leiomyomatosis: an original tumor]. Gynecol Obstet Fertil; 2007 Apr;35(4):323-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intravascular leiomyomatosis: an original tumor].
  • [Transliterated title] Léiomyomatose intravasculaire: une tumeur originale.
  • An unusual uterus benign tumor, intravascular leiomyomatosis is also a differential diagnosis of uterine fibromas.
  • [MeSH-major] Leiomyomatosis / diagnosis. Uterine Neoplasms / diagnosis. Vascular Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / prevention & control

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17336128.001).
  • [ISSN] 1297-9589
  • [Journal-full-title] Gynécologie, obstétrique & fertilité
  • [ISO-abbreviation] Gynecol Obstet Fertil
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


44. Ahmed Z, Aftab K, Kayani N: Ovarian primary neuroendocrine carcinoma of non-small cell type: report of an extremely rare neoplasm. J Pak Med Assoc; 2005 Feb;55(2):82-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ovarian primary neuroendocrine carcinoma of non-small cell type: report of an extremely rare neoplasm.
  • Paraffin block sections of a uterus and ovarian mass from a 31 year old female were sent for second opinion to the Pathology Laboratory of Aga Khan University.
  • Histologic examination and immunohistochemical features gave a diagnosis of primary neuroendocrine carcinoma of non-small cell type admixed with benign mucinous cystadenoma.
  • This is a rare tumour with only eight being reported in literature.
  • [MeSH-major] Carcinoma, Neuroendocrine / pathology. Cystadenoma, Mucinous / pathology. Ovarian Neoplasms / pathology

  • Genetic Alliance. consumer health - Ovarian small cell carcinoma.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15813637.001).
  • [ISSN] 0030-9982
  • [Journal-full-title] JPMA. The Journal of the Pakistan Medical Association
  • [ISO-abbreviation] J Pak Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


45. Dinas K, Daniilidis A, Drizis E, Zaraboukas T, Tzafettas J: Incidental diagnosis of atypical polypoid adenomyoma in a young infertile woman. Eur J Gynaecol Oncol; 2009;30(6):701-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidental diagnosis of atypical polypoid adenomyoma in a young infertile woman.
  • Atypical polypoid adenomyoma (APA) is considered to be a rare, benign form of a polypoid mass that exhibits glandular and squamous epithelial cell proliferation with varying degrees of atypia in association with cellular smooth muscle stroma.
  • The differential diagnosis of APA includes complex endometrial hyperplasia with atypia, invasive adenocarcinoma, adenofibroma, adenosarcoma and carcinosarcoma.
  • The recognition of these unusual benign uterine tumors is very important, because they can easily be misdiagnosed.
  • We present a case of an infertile 39-year-old woman with an incidental diagnosis of APA.
  • [MeSH-major] Adenomyoma / diagnosis. Infertility, Female / complications. Uterine Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Female Infertility.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20099510.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


46. Strissel PL, Swiatek J, Oppelt P, Renner SP, Beckmann MW, Strick R: Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients. J Steroid Biochem Mol Biol; 2007 Oct;107(1-2):42-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
  • Smooth muscle tumors are histologically separated into benign leiomyomas and malignant leiomyosarcomas.
  • Uterine leiomyomas represent benign clonal tumors often arising within the smooth muscle tissue of the human uterus.
  • Uterine leiomyomas develop after the start of the menstrual cycle, become symptomatic during middle age, and in most postmenopausal patients tumor regression occurs.
  • Rarely, leiomyomas progress to leiomyosarcomas, where many sarcomas have markedly reduced or no steroid hormone receptors, thus, evolve to a hormone non-responsive state.
  • Quantitation of steroid hormone receptors from benign uterine tumors may be important for a more tailored therapy.
  • In addition, a role for steroid hormones, specifically ERbeta, is discussed in terms of benign tumor regression or tumor maintenance in postmenopausal leiomyomas.
  • [MeSH-major] Estrogen Receptor alpha / biosynthesis. Estrogen Receptor beta / biosynthesis. Leiomyoma / metabolism. Postmenopause / metabolism. Receptors, Progesterone / biosynthesis. Uterine Neoplasms / metabolism

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17646097.001).
  • [ISSN] 0960-0760
  • [Journal-full-title] The Journal of steroid biochemistry and molecular biology
  • [ISO-abbreviation] J. Steroid Biochem. Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / RNA, Messenger; 0 / Receptors, Progesterone
  •  go-up   go-down


47. Hakverdi S, Dolapçioğlu K, Güngören A, Yaldiz M, Hakverdi AU: Multiple uterine angioleiomyomas mimicking an ovarian neoplasm: a case report. Eur J Gynaecol Oncol; 2009;30(5):592-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple uterine angioleiomyomas mimicking an ovarian neoplasm: a case report.
  • Angioleiomyoma is a rare benign neoplasm that originates from smooth muscle cells and contains thick-walled blood vessels.
  • At the exploration, a tumoral mass that could not be differentiated as to whether it had its origin from the uterus or ovary was specified.
  • On pathologic examination of the specimen, the tumor was diagnosed as an angioleiomyoma.
  • Here, we present a case of giant-multiple uterine angioleiomyomas mimicking an ovarian neoplasm.
  • [MeSH-major] Angiomyoma / diagnosis. Angiomyoma / pathology. Ovarian Neoplasms / diagnosis. Uterine Diseases / diagnosis. Uterine Diseases / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Hysterectomy. Ovariectomy

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19899426.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


48. Sun C, Wang XM, Liu C, Xv ZD, Wang DP, Sun XL, Deng K: Intravenous leiomyomatosis: diagnosis and follow-up with multislice computed tomography. Am J Surg; 2010 Sep;200(3):e41-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intravenous leiomyomatosis: diagnosis and follow-up with multislice computed tomography.
  • Intravenous leiomyomatosis is a rare disease, which appears histologically benign but is clinically aggressive.
  • Intravenous leiomyomatosis was reported to have originated in the uterus and extended into the right ventricle via the inferior vena cava (IVC).
  • Multislice compute tomography (MSCT) allows an early and accurate preoperative diagnosis, resulting in a higher rate of surgical resection and improved survival.
  • The authors present 3 cases of intravenous leiomyomatosis with a history of uterine leiomyoma and hysterectomy.
  • [MeSH-major] Heart Neoplasms / radiography. Heart Neoplasms / surgery. Iliac Vein. Leiomyomatosis / radiography. Leiomyomatosis / surgery. Lung Neoplasms / radiography. Lung Neoplasms / surgery. Tomography, Spiral Computed. Vena Cava, Inferior
  • [MeSH-minor] Adult. Collateral Circulation. Diagnosis, Differential. Female. Humans. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Intravenous leiomyomatosis.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20409533.001).
  • [ISSN] 1879-1883
  • [Journal-full-title] American journal of surgery
  • [ISO-abbreviation] Am. J. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement